Schemas and data models
Help define structures for submissions, descriptors, file records, and review reports.
Open-source ecosystem for in vitro and microphysiological systemsDevelopers
Developers help turn shared practices into reliable tools, schemas, validation resources, catalog features, and documentation.
Developer role
Developer work supports the practical workflow: contributors submit records, curators review them, users search approved metadata, and the community maintains reusable resources over time.
Contribution areas
Help define structures for submissions, descriptors, file records, and review reports.
Build checks that help contributors and curators find missing or inconsistent metadata.
Improve search, filtering, record display, and governed access workflows.
Create examples and guidance that make resources easier to adopt.
Quality
Technical contributions should include clear examples, expected behavior, and documentation so contributors and curators can use them confidently.
Get involved
Help improve schemas, validation resources, catalog tools, examples, or documentation.
Standards and manufacturing partners
Connect with the organizations advancing consensus standards, validation, and regenerative manufacturing across the PhysioVerse ecosystem.
The Microphysiological and Organoid Systems Standards Development Organization (MOSSDO) is a federally funded multi-stakeholder initiative focused specifically on establishing consensus-based standards for organoids, microphysiological systems (MPS), and body-on-a-chip technologies. MOSSDO develops frameworks for reproducibility, validation, and interoperability, enabling these platforms to be more reliably adopted across research, regulatory, and translational settings. In coordination with enabling ecosystem efforts such as PhysioVerse, MOSSDO provides the standards foundation that supports data integration, comparability, and broader field-wide adoption.
The Regenerative Manufacturing Innovation Consortium (RegMIC), founded in 2014, is a national initiative that brings together stakeholders from industry, academia, and government to advance the manufacturing, scale-up, and commercialization of regenerative technologies. Through cross-sector collaboration, RegMIC addresses key challenges in translation, including process development, regulatory alignment, and the establishment of best practices across cell, tissue, and advanced in vitro systems.